H.R. 237 (119th)Bill Overview

Paws Off Act of 2025

Health|Administrative law and regulatory proceduresAnimal protection and human-animal relationships
Cosponsors
Support
Republican
Introduced
Jan 7, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill (Paws Off Act of 2025) amends the Federal Food, Drug, and Cosmetic Act to require foods containing xylitol to carry a label warning that xylitol is toxic to dogs if ingested. Foods lacking that warning would be deemed misbranded.

Why people may split

Animal-safety benefits vs concerns about regulatory burden

Watch point

Relative to its intended legislative type, this bill is a straightforward statutory amendment that creates a new labeling obligation by deeming foods containing xylitol misbranded unless the label warns of xylitol's toxicity to dogs.

This bill (Paws Off Act of 2025) amends the Federal Food, Drug, and Cosmetic Act to require foods containing xylitol to carry a label warning that xylitol is toxic to dogs if ingested.

Foods lacking that warning would be deemed misbranded.

The Secretary of Health and Human Services (through the FDA Commissioner) must issue an interim final rule within 6 months and a final rule within 1 year to implement the requirement.

Passage40/100

Technically simple, low-salience consumer-protection measure with modest costs, raising a fair chance of enactment but subject to legislative calendar and any industry objections.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a straightforward statutory amendment that creates a new labeling obligation by deeming foods containing xylitol misbranded unless the label warns of xylitol's toxicity to dogs. It clearly integrates into the FD&C Act and prescribes short, specific rulemaking deadlines to effectuate the change.

Contention65/100

Animal-safety benefits vs concerns about regulatory burden

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Consumers · ManufacturersManufacturers · Small businesses

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • ConsumersReduces risk of canine xylitol poisonings by informing consumers about toxic effects.
  • ConsumersStandardizes labeling across products, providing consistent consumer information.
  • ManufacturersEncourages manufacturers to reformulate or package products to prevent pet exposures.
Likely burdened
  • ManufacturersImposes labeling compliance costs and potential redesign expenses on food manufacturers.
  • Small businessesSmall businesses and importers may face disproportionate financial and administrative burdens.
  • Potential burdenFDA will incur rulemaking and enforcement costs to implement and monitor the requirement.
03 · Why people split

Why the argument around this bill splits.

Animal-safety benefits vs concerns about regulatory burden
Progressive90%

Likely supportive because the measure protects animal welfare and public safety by informing consumers about a known canine toxin.

Views it as a narrow, evidence-based consumer protection that uses labeling rather than criminal penalties.

May push for inclusive warning language and outreach for non-English speakers.

Leans supportive
Centrist75%

Generally favorable but pragmatic: supports pet safety and federal clarity while wanting predictable, minimally burdensome implementation.

Wants clear specifications for warning wording, placement, and cost estimates.

Will look for evidence that benefits justify compliance costs and for reasonable timelines and small-business assistance.

Leans supportive
Conservative30%

Skeptical of additional federal labeling mandates and their costs; supportive of pet safety in principle but prefers voluntary industry guidance or state-level action.

Views the measure as federal overreach that could burden businesses, increase litigation risk, and expand FDA regulatory scope.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

Technically simple, low-salience consumer-protection measure with modest costs, raising a fair chance of enactment but subject to legislative calendar and any industry objections.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Industry pushback or lobbying intensity
  • FDA enforcement resources and priorities
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Animal-safety benefits vs concerns about regulatory burden

Technically simple, low-salience consumer-protection measure with modest costs, raising a fair chance of enactment but subject to legislati…

Unlocked analysis

Relative to its intended legislative type, this bill is a straightforward statutory amendment that creates a new labeling obligation by deeming foods containing xylitol misbranded unless the label warns of xylitol's tox…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis